87 related articles for article (PubMed ID: 3094455)
1. [In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Nagai S; Kamiya H; Sato K; Sakai K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2981-6. PubMed ID: 3094455
[TBL] [Abstract][Full Text] [Related]
2. [UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Inoue S; Shibata S; Okumura A; Tanaka T; Onitsuka Y; Yoshimura T; Aiko A; Ikuta Y; Fukuma K; Matsuura K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):499-504. PubMed ID: 3923940
[TBL] [Abstract][Full Text] [Related]
3. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Suzuki M; Sekiguchi I; Ohwada M; Tamada T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
[TBL] [Abstract][Full Text] [Related]
4. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative treatment with UFT for patients with ovarian malignant tumors].
Nagai S; Sawada T; Tsukasaki K; Kamiya H; Sakai K
Gan To Kagaku Ryoho; 1985 May; 12(5):1073-9. PubMed ID: 3922309
[TBL] [Abstract][Full Text] [Related]
6. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
[TBL] [Abstract][Full Text] [Related]
7. [The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Yamashita K; Mitani K; Morishita Y; Inoue K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):767-73. PubMed ID: 2496666
[TBL] [Abstract][Full Text] [Related]
8. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
9. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
[TBL] [Abstract][Full Text] [Related]
10. [5-FU concentration in brain tumors after co-administration of FT and uracil].
Nogaki H; Taomoto K; Tamaki N; Matsumoto S
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):1007-12. PubMed ID: 6307160
[TBL] [Abstract][Full Text] [Related]
11. [5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].
Fukunaga H; Katsumi M; Aoki Y; Oka S; Konishi R; Yukawa H; Kawaguchi T; Tamaki Y; Takifuji K
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2735-9. PubMed ID: 3115184
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Kagawa S; Takigawa H; Aga Y; Kurokawa K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
[TBL] [Abstract][Full Text] [Related]
13. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
[TBL] [Abstract][Full Text] [Related]
14. [UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
Kato H; Inoue S; Takahashi K; Yamanaka A; Okada Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1866-70. PubMed ID: 3036016
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
Takeyama M; Honjoh M; Ohnishi N; Ishikawa Y; Sakaguchi H; Hanai J
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1953-9. PubMed ID: 8215468
[TBL] [Abstract][Full Text] [Related]
16. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
[TBL] [Abstract][Full Text] [Related]
17. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
Somekawa Y; Asano K; Taira A; Imai R
Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473
[TBL] [Abstract][Full Text] [Related]
18. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
[TBL] [Abstract][Full Text] [Related]
19. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
20. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]